Yoona Chung

Yoona Chung

Auto-generated profile, based on publicly available information

Yoona Chung

Metabolic and Bariatric Surgery Center, Department of Surgery, H+ Yangji Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
YCYoona Chung
Yoona Chung
DPDae Geun Park
Dae Geun Park
YKYong Jin Kim
Yong Jin Kim
Laparoscopic sleeve gastrectomy (LSG) has become a standalone primary procedure as a bariatric metabolic surgery since the early 2000s. The overall complication rate of LSG is reported to range from 2% to 15%. Staple line leakage (SLL) remains a major adverse event and occurs in approximately 1–6% of patients. Choosing the optimal treatment modality is a complex process. Clinicians must understand that nutritional support and drainage of fluid collection are essential for initial management. Conservative endoscopic management and sufficient drainage can resolve approximately 70% of SLLs. Endoscopic management of bariatric complications has been rapidly evolving in recent years and can be considered in all patients who are hemodynamically stable. We will review the available endoscopic management techniques, including stent placement (self-expanding stents and bariatric-specific stents), clipping, tissue sealant application, and internal drainage (double-pigtail stents [DPS] placement, endoscopic vacuum therapy, and septotomy). Stent placement remains the mainstream treatment for SLLs. However, healing with stents requires multiple sessions/stents and a long course of recovery. Endoscopic internal drainage is gaining popularity and has the potential to be a superior method. The importance of early intervention and combined endoscopic methods should be recognized.

3 December 2018 in Hernia
Verified
Journal Article
Closed access
PDF file
YCY. Chung
Y. Chung
JCJ. W. Choi
J. W. Choi
HKH. C. Kim
H. C. Kim
SKS. H. Kim
S. H. Kim
SCSung Il Choi
Sung Il Choi

1 January 2019 in Journal of Gastric Cancer
Verified
Journal Article
Open access
SKSang Hyun Kim
Sang Hyun Kim
YCYoona Chung
Yoona Chung
YKYong Ho Kim
Yong Ho Kim
SCSung Il Choi
Sung Il Choi
Kim SH, et al. J Gastric Cancer. 2019 Jan;19:e4. https://doi.org/10.5230/jgc.2019.19.e4

1 January 2025 in Journal of Metabolic and Bariatric Surgery
Verified
Journal Article
Open access
YCYoona Chung
Yoona Chung
YKYong Jin Kim
Yong Jin Kim
SPSuyeon Park
Suyeon Park
Enhanced recovery after bariatric surgery is important for decreasing morbidity, enhancing functional recovery and shortening the length of stay. Ultrasound-guided transversus abdominis plane (TAP) block has been known to decrease pain scores and opioid requirement after bariatric surgery. We aimed to investigate the efficacy of continuous TAP block in 50 consecutive cases of laparoscopic sleeve gastrectomy (LSG). From February 2022 to April 2022, 50 cases of LSG were performed with ultrasound-guided TAP blocks. The data was compared to that of 157 cases of primary LSG that had been performed from January to December of 2021. Ultrasound guided TAP block was performed from the epigastric port site 3 to 5 mm in size that was placed for liver retraction during LSG. The lateral border of the rectus abdominis muscle was identified. A 17-gauge T-peel inducer and sheath (On-Q® Pain Buster®) were inserted in a medial to lateral direction towards the TAP. Fifteen to 20 mL of normal saline was injected for plane dissection and the catheter was inserted through the sheath after removal of the inducer. The same was performed for the other side in the same order. The elastomeric pump was injected with 100 mg of 0.5% bupivacaine and connected to the 2 catheters. There was no significant difference in mean age, initial body weight, preoperative body mass index (BMI), incidence of diabetes, hypertension, obstructive sleep apnea, and length of postoperative hospital stay between the TAP group and the non-TAP group. The TAP group had a higher incidence of dyslipidemia. There were statistically significant differences in the clinical outcomes regarding the numerical rating scale (NRS) score at postoperative 12, 24 and 48 hours, opioid injection within 24 hours (non-TAP group 36.82% vs. TAP group 20%, P value=0.037) and ramosetron injection within 24 hours (non-TAP group 9.45% vs. TAP group 0%, P value=0.017). There was no significant difference between the 2 groups in postoperative NRS scores at 1 and 6 hours, incidence of nausea or vomiting, injection of acetaminophen, non-steroidal anti-inflammatory drugs, or metoclopramide within 24 or 48 hours, injection of opioid or ramosetron within 48 hours. There were 2 cases of complications related to continuous TAP block where there was difficulty in removing the catheters and needed to be removed under local anesthesia. Although continuous TAP block did not reduce cumulative opioid consumption, the need for additional opioid and antiemetic injection can be reduced within the postoperative 24 hours.

25 October 2024 in Metabolism and Target Organ Damage
Verified
Journal Article
Open access
PDF file
YCYoona Chung
Yoona Chung
BPBomina Paik
Bomina Paik
DJDongjae Jeon
Dongjae Jeon
YKYong Jin Kim
Yong Jin Kim
Excess body weight impacts kidney function in individuals with severe obesity, primarily through metabolic alterations in adipocytes, especially in visceral adipose tissue. The relationship between persistent sterile inflammation associated with obesity and the progression of obesity-related kidney disease to chronic kidney disease (CKD) is an area of growing interest. The beneficial effects of weight loss on the prevention of kidney disease and the improvement of kidney function in individuals with obesity have been well documented. Currently, the most effective weight loss strategy is metabolic bariatric surgery (MBS), which has been proven to not only prevent the progression of CKD but also reverse it. However, awareness and understanding of the impact of obesity on the kidney should also extend to the severely obese population with clinically normal renal function. The purpose of this review is to outline the current knowledge on the pathophysiology of obesity-induced kidney damage, the effects of MBS on renal function in severely obese individuals with or without CKD, and provide the current evidence on perioperative management strategies for CKD patients, including diet and nutrition.

15 March 2020 in Journal of Minimally Invasive Surgery
Verified
Journal Article
Open access
PDF file
SKSang Kim
Sang Kim
KHKyung Yul Hur
Kyung Yul Hur
YCYoona Chung
Yoona Chung
YKYong Jin Kim
Yong Jin Kim
Sang Hyun Kim, M.D., Ph.D., Kyung Yul Hur, M.D., Ph.D., Yoona Chung, M.D., Yong Jin Kim, M.D., Ph.D.. Journal of Minimally Invasive Surgery 2020;23:52-6. https://doi.org/10.7602/jmis.2020.23.1.52